Cargando…

Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant

BACKGROUND: Ventricular assist devices(VAD) implantation/removal is a complex surgical procedure with perioperative bleeding complications occurring in nearly half of the cases. Recombinant activated factor VII (rFVIIa) has been used off-label to control severe hemorrhage in surgery and trauma. We r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Manish J, Pierce, Richard A, Zhang, Lini, Moon, Marc R, Despotis, George J, Moazami, Nader
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939840/ https://www.ncbi.nlm.nih.gov/pubmed/17617902 http://dx.doi.org/10.1186/1749-8090-2-32

Ejemplares similares

Commentary: Ventricular recovery with left ventricular assist device support: The failed quest for the Holy Grail?
por: Moazami, Nader, et al.
Publicado: (2021)

Predictors of right ventricular failure after left ventricular assist device implantation
por: Koprivanac, Marijan, et al.
Publicado: (2014)

Persistence of pulmonary hypertension in patients undergoing ventricular assist devices and orthotopic heart transplantation
por: Rajaratnam, Arun, et al.
Publicado: (2023)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Recombinant activated factor VII (Novo7(®)) in patients with ventricular assist devices: Case report and review of the current literature
por: Heise, Daniel, et al.
Publicado: (2007)

Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
por: Malone, Grainne, et al.
Publicado: (2022)

Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation
por: Gulati, Gunsagar, et al.
Publicado: (2017)

Transfusion Risks and Transfusion-related Pro-inflammatory Responses
por: Despotis, George John, et al.
Publicado: (2007)

Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device
por: Lee, Sangjin, et al.
Publicado: (2016)

Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends
por: Hurst, Thomas E., et al.
Publicado: (2019)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Delayed sternal closure does not reduce complications associated with coagulopathy and right ventricular failure after left ventricular assist device implantation
por: Yanagida, Roh, et al.
Publicado: (2017)

Bridge to Transplantation with a Left Ventricular Assist Device
por: Jung, Jae Jun, et al.
Publicado: (2012)

Left Ventricular Assist Device Followed by Heart Transplantation
por: Biselli, Bruno, et al.
Publicado: (2015)

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
por: Rizoli, Sandro B, et al.
Publicado: (2006)

Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections
por: Héquet, Delphine, et al.
Publicado: (2016)

New role of ventricular assist devices as bridge to transplantation: European perspective
por: Reineke, David C., et al.
Publicado: (2017)

HHV-6 Myocarditis Progressing to Ventricular Standstill Requiring Cardiac Transplant
por: Golob, Stephanie, et al.
Publicado: (2023)

The application of magnetic anchoring traction device in assisting donor liver bench surgery in classic orthotopic liver transplantation
por: Song, Jiashu, et al.
Publicado: (2022)

Sleeve Gastrectomy and Left Ventricular Assist Device for Heart Transplant
por: Greene, Joseph, et al.
Publicado: (2017)

Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation
por: Jha, Sunita R., et al.
Publicado: (2017)

Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
por: Ingvarsson, Annika, et al.
Publicado: (2022)

Coagulopathy during liver transplantation
por: Saracoglu, Ayten, et al.
Publicado: (2018)

Commentary: Supporting a left ventricular assist device to transplant, the right way
por: Ising, Mickey S., et al.
Publicado: (2022)

Right and left ventricular assist devices are an option for bridge to heart transplant
por: Barac, Yaron D., et al.
Publicado: (2022)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

Ventricular assist devices in pediatrics
por: Fuchs, A, et al.
Publicado: (2001)

Pediatric Ventricular Assist Device
por: Shin, Yu Rim, et al.
Publicado: (2019)

Commentary: Heart transplantation from donation after circulatory death: Coming to a hospital near you
por: Smith, Deane, et al.
Publicado: (2022)

Preliminary experience with continuous right ventricular pressure and transesophageal echocardiography monitoring in orthotopic liver transplantation
por: Miles, Lachlan F., et al.
Publicado: (2022)

Outcome of Extracorporeal Ventricular Assist Device for Cardiogenic Shock as a Bridge to Transplantation
por: Kim, Hyo-Hyun, et al.
Publicado: (2020)

The endogenous thrombin potential in patients with left ventricular assist device or heart transplant
por: Schlagenhauf, Axel, et al.
Publicado: (2023)

Optimal timing of heart transplantation in patients with an implantable left ventricular assist device
por: Sohn, Suk Ho, et al.
Publicado: (2023)

Bilateral lung transplantation from a left ventricular assist device supported donor
por: Choi, Kukbin, et al.
Publicado: (2023)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Orthotopic Liver Transplantation in Rats
por: Oldani, Graziano, et al.
Publicado: (2012)

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n9dr0bt9iv1n1rlb7hqjh56j3v